AU4288593A - Method and composition for the detection of lesions - Google Patents

Method and composition for the detection of lesions

Info

Publication number
AU4288593A
AU4288593A AU42885/93A AU4288593A AU4288593A AU 4288593 A AU4288593 A AU 4288593A AU 42885/93 A AU42885/93 A AU 42885/93A AU 4288593 A AU4288593 A AU 4288593A AU 4288593 A AU4288593 A AU 4288593A
Authority
AU
Australia
Prior art keywords
lesions
detection
composition
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU42885/93A
Inventor
T. Edward Bynum
Lajos Nagy
Sandor Szabo
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Brigham and Womens Hospital Inc
Original Assignee
Brigham and Womens Hospital Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Brigham and Womens Hospital Inc filed Critical Brigham and Womens Hospital Inc
Publication of AU4288593A publication Critical patent/AU4288593A/en
Abandoned legal-status Critical Current

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/74—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving hormones or other non-cytokine intercellular protein regulatory factors such as growth factors, including receptors to hormones and growth factors
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6872—Intracellular protein regulatory factors and their receptors, e.g. including ion channels
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6893—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids related to diseases not provided for elsewhere

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Chemical & Material Sciences (AREA)
  • Biomedical Technology (AREA)
  • Hematology (AREA)
  • Immunology (AREA)
  • Urology & Nephrology (AREA)
  • Cell Biology (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • Food Science & Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Endocrinology (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
AU42885/93A 1992-04-15 1993-04-15 Method and composition for the detection of lesions Abandoned AU4288593A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US86956792A 1992-04-15 1992-04-15
US869567 1992-04-15

Publications (1)

Publication Number Publication Date
AU4288593A true AU4288593A (en) 1993-11-18

Family

ID=25353820

Family Applications (1)

Application Number Title Priority Date Filing Date
AU42885/93A Abandoned AU4288593A (en) 1992-04-15 1993-04-15 Method and composition for the detection of lesions

Country Status (2)

Country Link
AU (1) AU4288593A (en)
WO (1) WO1993021531A1 (en)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU658257B2 (en) * 1991-10-31 1995-04-06 Matritech, Inc. Nuclear matrix protein fluid assay

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1989011099A1 (en) * 1988-05-07 1989-11-16 Yamasa Shoyu Kabushiki Kaisha Anti-endoserine antibody

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU658257B2 (en) * 1991-10-31 1995-04-06 Matritech, Inc. Nuclear matrix protein fluid assay

Also Published As

Publication number Publication date
WO1993021531A1 (en) 1993-10-28

Similar Documents

Publication Publication Date Title
HU9401580D0 (en) Method for the preparation and popification of alphia - interferon
AU7270091A (en) Method and composition for coiontophoresis
AU4230193A (en) Method and system for topograhic measurement
AU659183B2 (en) Surfactant composition and method of making the same
AU3633895A (en) Defoamer composition and method of using the same
AU5495790A (en) Two-part aerosol composition and method for increasing the light-reflectivity of an object
AU6400294A (en) Tripterinin compound and method
AU6955594A (en) Aminoureaformaldehyde fertilizer method and composition
AU1193092A (en) Granulated pharmaceutical composition and method of obtaining it
AU3406893A (en) Method and composition for the treatment of osteoporosis
AU4489693A (en) Apparatus and methods for improved construction
AU4496697A (en) Materials and methods for detection of (oxalobacter)
AU3385693A (en) Determination method
AU7395194A (en) Neomorphic ibuprofen and methods of using same
AU7008394A (en) Methods and compositions for detection of (salmonella)
AU6368394A (en) Polymer-polypeptide composition and method
AU2479495A (en) Materials and methods for the detection of mycobacteria
AU4505996A (en) 7-vinylidene cephalosporins and methods of using the same
AU651402B2 (en) Composition and method for preventing fluorosis
EP0583687A3 (en) Method for the preparation of substituted methoxyphenols and microorganisms therefore
AU1225492A (en) Process for the detection and localization of cancer
AU5957794A (en) Compositions and method for the inhibition of phagocytes
AU7506896A (en) Method for the simultaneous detection of polygenes
AU6575594A (en) Point of incidence detection
AU4288593A (en) Method and composition for the detection of lesions